Your browser doesn't support javascript.
loading
Changing bulking agent may require change in injection volume for endoscopic treatment of vesicoureteral reflux
Tekin, Ali; Yagmur, Ismail; Tiryaki, Sibel; Dokumcu, Zafer; Ulman, Ibrahim; Avanoglu, Ali.
  • Tekin, Ali; Ege University Faculty of Medicine. Department of Pediatric Surgery. Izmir. TR
  • Yagmur, Ismail; Ege University Faculty of Medicine. Department of Pediatric Surgery. Izmir. TR
  • Tiryaki, Sibel; Ege University Faculty of Medicine. Department of Pediatric Surgery. Izmir. TR
  • Dokumcu, Zafer; Ege University Faculty of Medicine. Department of Pediatric Surgery. Izmir. TR
  • Ulman, Ibrahim; Ege University Faculty of Medicine. Department of Pediatric Surgery. Izmir. TR
  • Avanoglu, Ali; Ege University Faculty of Medicine. Department of Pediatric Surgery. Izmir. TR
Int. braz. j. urol ; 44(6): 1194-1199, Nov.-Dec. 2018. tab, graf
Article in English | LILACS | ID: biblio-975658
ABSTRACT
ABSTRACT

Introduction:

Various bulking agents were utilized for endoscopic correction of VUR. A study reviewing multi-institutional data showed that the amount of injection material has increased over time with the purpose of improving success rates, which also resulted in costs. We noticed an opposite trend in our center since we started using a new bulking agent. The aim of this study was to evaluate evolution of our practice with different bulking agents. Patients and

Methods:

Records of VUR patients who underwent subureteric injection with polyacrylate polyalcohol copolymer (PPC) and dextronomere hyaluronic acide (DxHA) between 2005 and 2014 were reviewed. Variation of different parameters throughout the study period was evaluated along with the success rate. Success was defined as complete resolution of reflux.

Results:

A total of 260 patients with 384 refluxing units were included. The success rate was higher in PPC group compared to DxHA group. There was no statistically significant difference between years regarding distribution of VUR grade, body weight, patient height, and age in PPC group. Despite significant reduction in injection volume, success rate did not decrease through the years with PPC.

Conclusion:

Different bulking agents may require different injection volumes to achieve the same success rate in endoscopic treatment of vesicoureteral reflux. Habits gained with previous experience using other materials should be revised while using a new agent.
Subject(s)


Full text: Available Index: LILACS (Americas) Main subject: Polymers / Vesico-Ureteral Reflux / Biocompatible Materials / Acrylic Resins / Dextrans / Hyaluronic Acid Type of study: Observational study / Prognostic study Limits: Child / Child, preschool / Humans Language: English Journal: Int. braz. j. urol Journal subject: Urology Year: 2018 Type: Article Affiliation country: Turkey Institution/Affiliation country: Ege University Faculty of Medicine/TR

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Index: LILACS (Americas) Main subject: Polymers / Vesico-Ureteral Reflux / Biocompatible Materials / Acrylic Resins / Dextrans / Hyaluronic Acid Type of study: Observational study / Prognostic study Limits: Child / Child, preschool / Humans Language: English Journal: Int. braz. j. urol Journal subject: Urology Year: 2018 Type: Article Affiliation country: Turkey Institution/Affiliation country: Ege University Faculty of Medicine/TR